Remedi Speciality Medicines Llp - Company Profile

It is a pharma limited liability partnership based in Chennai, Tamil Nadu, India, established in 2016.
2016 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Remedi Speciality Medicines Llp

Remedi Speciality Medicines Llp, a active limited liability partnership, was established on 02 March 2016 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAF-8361. Registered under ROC Roc Chennai. It has total obligation of contribution of ₹1.20 M.

Its leadership includes Ashishkumar (Designated Partner), Babithajain (Designated Partner), Anil Kumar Jain Shanta (Designated Partner). Past directors included Anilkumar Jain, Saurab Jain. Its latest date of accounts and solvency statement 31 March 2023. It is based at New No.9/1, Old No.15/1, Ground Floor Krishna Bai Street, T. Nagar, Chennai, Tamil Nadu, 600017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAF-8361

  • Incorporation Date

    02 March 2016

  • Total Obligation of Contribution

    ₹1.20 M

  • ROC Code

    Roc Chennai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.20 M
  • Company Age 10 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Remedi Speciality Medicines Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Remedi Speciality Medicines Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Remedi Speciality Medicines Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ashishkumar Designated Partner 01 Apr 2021 Current
Babithajain Designated Partner 01 Apr 2021 Current
Anil Kumar Jain Shanta Designated Partner 01 Apr 2021 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 01 Apr 2021 Past
Pramod Abcsdd Designated Partner 19 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Remedi Speciality Medicines Llp.

Enhance accessibility to Remedi Speciality Medicines Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Remedi Speciality Medicines Llp revenue growth over time
Remedi Speciality Medicines Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Remedi Speciality Medicines Llp?

Unlock access to Remedi Speciality Medicines Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Remedi Speciality Medicines Llp?

Unlock and access historical data on people associated with Remedi Speciality Medicines Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Remedi Speciality Medicines Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remedi Speciality Medicines Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Remedi Speciality Medicines Llp
Recent Activity within the Organization
  • Annual General Meeting

    Remedi Speciality Medicines Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Remedi Speciality Medicines Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai. was recorded as a recent event.

  • Director Appointment

    Progress on Ashishkumar was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2021 & has been associated with this company since 5 years 1 month . was documented.

  • Director Appointment

    Progress on Babithajain was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2021 & has been associated with this company since 5 years 1 month . was documented.

  • Director Appointment

    Progress on Anil Kumar Jain Shanta was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2021 & has been associated with this company since 5 years 1 month . was documented.

  • LLP Incorporation

    Progress on Remedi Speciality Medicines Llp was registered on 02 Mar 2016 with Roc Chennai & aged 10 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Remedi Speciality Medicines Llp?

The LLPIN of Remedi Speciality Medicines Llp is AAF-8361.

Where is Remedi Speciality Medicines Llp headquartered?

Remedi Speciality Medicines Llp is headquartered at New No.9/1, Old No.15/1, Ground Floor Krishna Bai Street, T. Nagar, Chennai, Tamil Nadu, 600017.

When was Remedi Speciality Medicines Llp incorporated?

Remedi Speciality Medicines Llp was incorporated on 02 March 2016.

Who are the current directors of Remedi Speciality Medicines Llp?

The current directors of Remedi Speciality Medicines Llp are

What is the primary industry of Remedi Speciality Medicines Llp?

The primary industry of Remedi Speciality Medicines Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available